Sort
146,196 grants matching “diabetes”
DCTD Biopharmaceutical Development
$11,541,306Larry Arthur · Science Applications International Corp · N01 · FY2009 · CA
The Long Life Family Study
$11,510,915Michael A Province · Washington University · U19 · FY2022 · AG
Laboratory, Data Analysis and Coordinating Center (LDACC)
$11,456,269 · N01 · FY2010 · HL
Data Coordinating Center
$11,365,000University Of South Florida · U01 · FY2004 · DK
The Ischemia Trial - CCC
$11,262,237Judith S Hochman · New York University School Of Medicine · U01 · FY2012 · HL
Type 1 Diabetes Trialnet: Operations Coord. Center
$11,185,161John M Lachin · George Washington University · U01 · FY2007 · DK
Adult Changes in Thought (ACT) Research Program
$11,060,502Linda Kathleen McEvoy · Kaiser Foundation Research Institute · U19 · FY2023 · AG
Cardiovascular Inflammation Reduction Trial (CIRT)
$11,048,538Paul M. Ridker · Brigham And Women'S Hospital · U01 · FY2016 · HL
Adult Changes in Thought (ACT) Research Program
$11,040,953Linda Kathleen McEvoy · Kaiser Foundation Research Institute · U19 · FY2024 · AG
ADDING ADDITIONAL FUNDS UNDER OPTION PERIOD 1, TASK AREAS 5 AND 6, FOR CORE YEAR 5.
$10,953,299Ashlin Bolton · Broad Institute, Inc. · N01 · FY2021 · HL
Insulin Resistance Intervention after Stroke (IRIS) Trial
$10,887,994Walter N Kernan · Yale University · U01 · FY2009 · NS
Adult Changes in Thought (ACT) Research Program
$10,767,047Jennifer Nelson · Kaiser Foundation Research Institute · U19 · FY2022 · AG
CMPB Central Pathology Support
$10,694,273Robert Sills · National Institute Of Environmental Health Sciences · ZIG · FY2012 · ES
Biospecimen Core
$10,682,132Bharat Thyagarajan · Washington University · U19 · FY2022 · AG
PRagmatic EValuation of evENTs And Benefits of Lipid-lowering in oldEr Adults (PREVENTABLE)
$10,663,839Karen P Alexander · Duke University · U19 · FY2019 · AG
Human Islet Distribution Coordinating Center
$10,645,002Joyce Carol Niland · Beckman Research Institute/City Of Hope · UC4 · FY2017 · DK
Iron-CLAD: securely advancing AoU participant characterization with provenplatforms and collaborations
$10,617,863Melissa A Haendel · University Of Colorado Denver · OT2 · FY2023 · OD
Vitamin D and type 2 diabetes (D2d)
$10,610,574Anastassios G Pittas · Tufts Medical Center · U01 · FY2014 · DK
DRCR Retina Network
$10,500,000Adam R Glassman · Jaeb Center For Health Research, Inc. · UG1 · FY2025 · EY
PRagmatic EValuation of evENTs And Benefits of Lipid-lowering in oldEr Adults (PREVENTABLE)
$10,487,354Karen P Alexander · Duke University · U19 · FY2025 · AG
Clinical and Translational Science Collaborative of Cleveland
$10,475,754Pamela B Davis · Case Western Reserve University · UL1 · FY2012 · TR
Data Coordinating Center for Type 1 Diabetes TrialNet
$10,334,077Jeffrey P Krischer · University Of South Florida · U01 · FY2024 · DK
Inter- and Intra-Species Comparative Sequencing
$10,295,725James C Mullikin · National Human Genome Research Institute · ZIB · FY2022 · HG
Clinical Research and Protocol Support Services
$10,194,940William O'Donnell · National Eye Institute · ZID · FY2024 · EY
Clinical and Translational Science Collaborative of Cleveland
$10,156,543Pamela B Davis · Case Western Reserve University · UL1 · FY2014 · TR